1 report

  • COMPANY OVERVIEW
  • EQUITY OFFERING

Wilex' s pipeline products are focused at treating multiple myeloma, prostate cancer, hematological cancers, metastatic pancreatic cancers, leukemia, non- metastatic ccRCC, kidney cancers and solid tumors.

  • Cancer
  • Pharmaceutical
  • United States
  • Company Financials
  • WILEX AG